Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

      FDA Approvals
      AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US FDA has granted Breakthrough Therapy Designation (BTD) for MEDI8897, an...

      Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

      Drug Development
      Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM announced a technology partnering and collaboration agreement. This agreement creates the...

      TrakCel, WindMIL Therapeutics Partner to Develop Supply Chain Platform

      Manufacturing
      TrakCel—a software developer for cell and gene therapy supply chain tracking and orchestration systems—and WindMIL Therapeutics—a clinical-stage oncology cell therapy company—have formed a partnership...

      Certara Launches Version 18 of Its Physiologically-based Pharmacokinetic Simcyp Simulator

      Drug Development
      Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced the launch of version 18 of its...

      SGS expands testing capabilities at Glasgow facility

      Facilities & Operation
      Bio/pharmaceutical analytical and bioanalytical contract solutions provider, SGS, has announced that it has invested £7.6 million in its facility in Glasgow, UK to expand...

      Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK

      FDA Approvals
      Neovasc Inc., a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for...

      Sanofi secures FDA approval for flu vaccine in children

      FDA Approvals
      Sanofi has received approval from the US FDA for 0.5ml Fluzone Quadrivalent vaccine to treat influenza in children aged between six and 35 months. Sanofi...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.